CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 20 enrolled
Drug / intervention
LipiScan Coronary Imaging Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00905671
NCT00905671Phase 4Completed

Study of Lipid Core Plaque Shift at Sites of Native Coronary Artery Bifurcation

Infraredx·interventional·Posted May 20, 2009·Updated Sep 4, 2014

In Brief

A Phase 4 clinical trial evaluating LipiScan Coronary Imaging Catheter for Angina Pectoris and 3 related conditions. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This pilot study is going to examine the hypothesis that in coronary arteries, soft lesions that contain lipid cores, but are not calcified or fibrotic and are located in proximity to side branches, are associated with side branch compromise as a result of plaque shift during angioplasty and stenting. Plaque characteristics will be detected by intravascular near infrared spectroscopy (NIRS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsColumbia University

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 20, 2009
Enrollment StartJun 1, 2009
Primary CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 17.1 years ago

Interventions

LipiScan Coronary Imaging Catheterdevice

Intravascular near infrared spectroscopic imaging of the coronary artery with a fiberoptic catheter.